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Trimethyltin (TMT) is a toxic organotin compound that induces acute neuronal death selectively in the hippocampal dentate
gyrus (DG) followed by cognition impairment; however the TMT-injured hippocampal DG itself is reported to regenerate the
neuronal cell layer through rapid enhancement of neurogenesis. Neural stem/progenitor cells (NS/NPCs) are present in the adult
hippocampal DG, and generate neurons that can function for the cognition ability. Therefore, we investigated whether royal
jelly (RJ) stimulates the regenerating processes of the TMT-injured hippocampal DG, and found that orally administered RJ
signiﬁcantly increased the number of DG granule cells and simultaneously improved the cognitive impairment. Furthermore, we
have already shown that RJ facilitates neurogenesis of cultured NS/NPCs. These present results, taken together with previous
observations, suggest that the orally administered RJ may be a promising avenue for ameliorating neuronal function by
regenerating hippocampal granule cells that function in the cognition process.
Royal jelly (RJ) is a substance synthesized by the lower
pharyngeal gland of the honeybee, and is thought to play
important nutritional roles for the queen honeybee. RJ
consists mainly of proteins, sugars, lipids, vitamins and free
amino acids [1–3], and has a variety of biological activities
toward various types of cells [4–7]. Earlier we reported
that RJ induces neurite outgrowth from cultured PC12 cells
[8, 9], a cell line of rat pheochromocytoma, via adenosine
A2A receptors, and enhances the phosphorylation of both
extracellular signal-regulated kinase 1 or 2 (ERK1/2) and
cAMP-response element-binding protein (CREB) in both
PC12 cells [9, 10] and cultured neural stem/progenitor cells
(NS/NPCs) [11]. cAMP-dependent signaling plays crucial
roles in the hippocampal long-term potentiation associated
with the ability for learning and memory [12, 13]. These
observations suggest that RJ can activate intracellular sig-
naling pathways by acting through adenosine A2A receptors,
with the result being hippocampal long-term potentiation.
However, there are no reports so far showing the eﬀects of RJ
on the recognition ability for learning and memory.
Trimethyltin (TMT) is a toxic organotin compound that
induces acute neuronal death selectively in the hippocampal
dentate gyrus (DG) [14–16] followed by cognition impair-
ment [17, 18]. However, the TMT-injured hippocampal
DG itself is reported to regenerate the neuronal cell layer
through rapid enhancement of neurogenesis [16]. NS/NPCs
are present in the adult hippocampal DG, and they can gen-
erate neurons that can function in cognition. Furthermore,
we have already shown that RJ facilitates neurogenesis of
culturedNS/NPCs.Therefore,TMT-treatedmiceareauseful
animal model to study neurogenesis in association with the
ability for learning and memory.
In this study, we examined whether RJ could ameliorate
TMT-induced cognitive impairment.
1.MaterialsandMethods
1.1. Materials. TMT was purchased from Sigma (St Louis,
MO); and toluidine blue, from WALDECK-Gmbh & CoKG
(Munster, Germany). RJ produced by Apis melifera (lot
no T07080728R) was provided by Api Co., Ltd (Gifu,
Japan). Chemical composition analysis demonstrated that
the RJ used for the present study consisted of moisture
(63.6%), proteins (14.5%) and 10-hydroxy-trans-2-decenoic
acid (1.98%), demonstrating that a quite usual RJ was
used. The RJ was lyophilized to a powder and mixed with























































































Figure 1: Eﬀect of TMT on the spontaneous alternation behavior (A) and number of neurons in the hippocampal DG (B and C). (A) Mice
were injected with a single dose of TMT (2mg kg−1), and subjected to the spontaneous alternation test in the Y-maze every day for 8 days
after the day of TMT injection. The ordinate shows the total alternation opportunities (total arm entries, a) and percentage alternation
(b) for 8min in each test. The values (the mean±SE; n=3–5) obtained 2 or 8 days after the treatment were signiﬁcantly lower than the
original value, determined by one-way ANOVA with Tukey’s test, ∗P< .05 and ∗∗P< .01, respectively. (B) Photographs of Nissl-stained
hippocampal DG of mice 2 days after treatment with PBS (a), or TMT (b). Scale bar: 50µm. (C) Number of granule cells in the hippocampal
DG 2 days after PBS (a) or TMT (b) treatment. The values are expressed as the mean±SE (n=4). The diﬀerence between the two values was
determined by Student’s t-test to be signiﬁcant at ∗∗∗P< .001.
1.2. Animals and Treatment of Animals. Male ICR mice (7
weeks old, 33–40g body weight) were purchased from Japan
SLC, Inc. (Shizuoka, Japan), and maintained in a controlled
environment (23±1◦C, 55±10% humidity) with a 12h
light–dark (8:00–20:00) cycle, and allowed unlimited access
to food and water. The animals were cared for according to
the international guidelines set out in the NIH publication
Principles of Laboratory Animal Care.
The mice were divided into two groups (n=24 each).
One group was treated with a single injection of TMT
(2mgkg−1, TMT group); and the other, with an injection
of phosphate-buﬀered saline [PBS], PBS group). Each group
was subdivided into three groups fed regular food (control,
n=8 or 10) or regular food containing 1% or 5% RJ (n=8,
each) 2 days after the treatment with TMT or vehicle. There
was no diﬀerence among the three groups in behavioral
scoresatthetimeofsubdivision.After6daysofconsumption
of the various diets the mice were subjected to behavioral
tests.
1.3. Spontaneous Alternation Test in a Y-Maze. The maze
was made of brown water-repellent corrugated cardboard;
each arm was 40cm long, 12cm high, 3cm wide at the
bottom and 10cm wide at the top. The arms converged
at an equilateral triangular central area that was 4cm at
its longest axis. The procedure was basically the same as
described previously [19]. Each mouse was placed at one of
thearmsoftheapparatusandallowedtomovefreelythrough
the maze during an 8min session. The series of arm entries
was recorded. Alternation was deﬁned as successive entry
into the three arms on overlapping triplet sets. Alternation
behavior(%)wascalculatedastheratioofactualalternations
topossiblealternations(deﬁnedasthenumberofarmentries
minus 2) multiplied by 100.
All results were expressed as the mean±SE for each
group. Simple comparisons of the means and SE of data were
performed by using Student’s t-test. Multiple comparisons
between groups were made by one-way ANOVA, and then
diﬀerences among means were analyzed by performingEvidence-Based Complementary and Alternative Medicine 3
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Figure 2: Amelioration of the TMT-induced impairment of short-term memory by the feeding with RJ. Mice were processed according to
the schedule illustrated in (a). The mice were treated with TMT in PBS or PBS alone on day 0, and feeding with RJ (0, 1 or 5%) for 6 days
was started from day 2. The spontaneous alternation behavior test was performed on day 8. The ordinates in (b) and (c) show the total
alternation opportunities (total arm entries) and percentage of alternation, respectively, measured for 8min. The values are expressed as the
mean±SE (n=8–10). The diﬀerence between the control value (PBS-treated mice fed without RJ) and that for the TMT-treated mice fed
without RJ diet was signiﬁcant at ∗P< .05 by one-way ANOVA with Holm’s test. #P< .05, TMT-treated mice with versus without RJ (5%).
Tukey’s test for the same number of experimental samples
in a group or Holm’s test for diﬀerent ones in a group.
1.4. Biochemical Analyses. After the behavioral test battery,
the mice were sacriﬁced by asphyxiation, and their brains
were removed and cut in half sagittally. The hemispheres
wererandomlychosenfromeachgroupforeachbiochemical
analysis, and embedded in paraﬃn. Serial brain sections
of 8µm in thickness including the hippocampal DG were
prepared, from which ﬁve sections were selected, with one
of every two consecutive sections taken. The sections were
stained with neuron-speciﬁc Nissl staining using 0.5% tolu-
idine blue solution for 25min. They were then dehydrated,
incubated in ammonia solution for 5min, and then enclosed
in resin that had been dissolved in xylene. The number of the
neurons with a diameter of over 10µm was counted without
any biases in 1mm2 a r e a so ft h eD Gg r a n u l ec e l ll a y e r .
2. Results
2.1. TMT Reduced Neuronal Cell Number and Impaired
Alteration Behavior Rate. To evaluate the eﬀect of TMT on
short-term memory or neuronal damage of the DG, we
intraperitoneally injected a single dose of TMT into mice
(2.0mg kg−1) at day 0. TMT attenuated the spontaneous
alternation behavior ﬁrst on day 2, which was restored
on days 3 or 5, but impaired it secondarily on day 8
(Figure 1(A)). As there was no signiﬁcant diﬀerence in the
number of arm entries (data not shown), mice used were
suggestedtohavethesamelevelsofmotivation,curiosityand
motorfunction.Namely,TMTcausedbothacute(day2)and
non-acute (day 8) impairments of the alternation behavior.
To clarify a link of the alternation behavioral drawback
to the neuronal damage of the DG, we focused on the
acute eﬀect that occurred on experimental day 2. The
brain sections from mice on day 2 were Nissl-stained,
and evaluated for neuronal damage to the DG. The TMT-
treated mice showed nearly a 50% marked reduction in the
number of DG neurons (Figures 1(B) and 1(C)), suggesting
that a half of the DG neurons were vulnerable to acute
toxicity of TMT and that this neuronal loss was responsible
for the impaired acute spontaneous alternation behavior
(Figure 1(A)). These observations are in good agreement
with those of a previous report [16], which suggested that
neurogenesis in the DG occurs several days after TMT
treatment. Therefore, the behavioral restoration found on
e x p e r i m e n t a ld a y s3o r5( Figure 1(A)) is likely to be a
consequence of the neurogenesis spontaneously evoked in




































Figure 3: Amelioration by RJ of the TMT-induced damage to the hippocampal DG. (A) Photographs of Nissl-stained hippocampal DG of
mice 8 days after PBS (a), or TMT (b) treatment, or TMT treatment+6-day feeding of 5% RJ diet (c). Scale bar: 50µm. (B) Number of
granule cells in the hippocampal DG of mice 8 days after PBS (a), or TMT treatment (b), or TMT treatment+6-day feeding of 5% RJ diet
(c). The values are expressed as the mean±SE (n=4). The diﬀerence between the control value (PBS-treated mice fed without RJ) and that
for TMT-treated mice fed without RJ diet was signiﬁcant at ∗∗P< .01 by Tukey’s test. ##P< .01, TMT-treated mice with versus without RJ.
death in the DG on day 2, and later attenuate neurogenesis
in the DG around day 8. Therefore, we next evaluated the
ameliorating eﬀect of RJ on the alternation behavior and the
cell number of the DG on day 8.
2.2. RJ Attenuated TMT-Induced Impairment of Spontaneous
Alternation Rate and Neuronal Damage. According to the
experimental schedule shown in Figure 2(a),m i c ew e r e
injected with TMT in PBS or PBS alone on day 0 and
successively fed the RJ-containing diet for 6 days, from days
2 to 7; and the spontaneous alternation rate and neuronal
cell number were then evaluated on day 8. TMT treatment
signiﬁcantlyimpaired thespontaneous alternationratewhen
evaluated on day 8; however, the feeding with the diet of 5%
RJ, but not 1% RJ, signiﬁcantly suppressed this impairment
(Figure 2(c)). As there was no signiﬁcant diﬀerence in the
number of arm entries among the groups (Figure 2(b)), RJ
did not aﬀect the locomotion activity. After the behavioral
test,themicewereﬁxedwith4%paraformaldehydesolution,
and brain sections were prepared and stained. As shown in
Figure 3(A), TMT-treated mice without the RJ diet (A, b)
appeared to have a smaller number of neurons than TMT-
non-treated mice without the RJ diet (A, a); whereas the
TMT-treated mice with the RJ diet (A, c) appeared to have a
greater number of neurons than TMT-treated ones without
it. Actual cell counting demonstrated that the TMT-induced
decrease in the number of neurons on day 8 (Figure 3(B), b)
was signiﬁcantly attenuated by RJ feeding (Figure 3(B), c).
3. Discussion
It is known that NS/NPCs reside in the hippocampal
DG of adult animals, where these cells proliferate andEvidence-Based Complementary and Alternative Medicine 5
diﬀerentiate into neurons [20–23] in response to injury
[21, 22], suggesting that the activation of NS/NPCs by some
agents or substances to promote neurogenesis facilitates
repair of the injured brain. Neurogenesis in the adult
DG is largely responsible for regulating the number of
granule cells, which cells are involved in the cognitive ability
[24].
In this study, we aimed at evaluating if orally admin-
istered RJ could facilitate the generation of hippocampal
DG granule cells in vivo. TMT is reported to induce acute
neuronal death selectively in the DG [14–16], but the
neurons substantially regenerate in several days, suggesting
that TMT-treated mice are useful as an in vivo model to
study neurogenesis [16]. Ogita et al. [16] demonstrated that
the administration of TMT induced acute neuronal death
in the DG selectively 2 days later and that 5-bromo-2 -
deoxyuridine (BrdU) incorporation into the DG cells was
facilitated at an early stage (days 2–5) after the damage by
TMT treatment. The BrdU-positive cells were also positive
for nestin, NeuroD3, doublecortin or NeuN, suggesting that
they were neural progenitor cells or neuronal precursors.
From these results, they concluded that the hippocampal
DG itself is capable of regenerating the neuronal cell layer
through rapid enhancement of neurogenesis after TMT-
induced injury.
Therefore, we investigated the eﬀect of RJ on the neuro-
genesis of the DG using this animal model. We found that
the oral administration of RJ for 6 days could signiﬁcantly
increase the number of Nissl-stained cells in the TMT-
damaged DG on experimental day 8 when the TMT-induced
neurogenesis would have ceased (Figure 3). It is conceiv-
able that these generated neurons were functional, because
RJ simultaneously ameliorated the cognitive impairment
(Figure 2).
Our recent results highlighted a novel property of RJ,
that is, that it facilitates the diﬀerentiation of all types
of brain cells including neurons from cultured NS/NPCs
[10], suggesting that RJ contains plural components that
diﬀerently inﬂuence neuronal and/or glial lineages. There-
fore, it might be expected that RJ or its components would
facilitate in vivo neurogenesis in the hippocampal DG. In
fact, adenosine monophosphate (AMP) N1-oxide, which we
earlier we identiﬁed to be a neurotrophic component of
RJ [8], facilitates the generation of astrocytes from NS/PCs
through activation of STAT3 [25]. On the other hand, 10-
hydroxy-trans-2-decenoic acid, an unsaturated fatty acid
characteristic of RJ, increases the generation of neurons
and decreases that of astrocytes and oligodendrocytes
from NSCs [10], suggesting that this compound unique
to RJ is a predominant contributor to the neurogene-
sis.
Based on the results of the present study, we propose that
RJ can facilitate neurogenesis in vivo, which suggests that
RJ may serve a tool for protection against and therapy for
some particular neurological disorders such as depression,
whose etiology is associated with reduced hippocampal
DG neurogenesis [26]. RJ has the potential of being a
promising evidence-based complementary and alternative
medicine.
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